Evaluating PN 400 (VIMOVO) in Reducing Gastric Ulcers Compared to Non-steroidal Antiinflammatory Drug (NSAID) Naproxen

PHASE3CompletedINTERVENTIONAL

Enrollment

434

Participants

Timeline

Start Date

September 30, 2007

Primary Completion Date

October 31, 2008

Study Completion Date

October 31, 2008

Conditions

Gastric Ulcer

Interventions

DRUG

PN400 (VIMOVO)

PN400 tablets (Naproxen 500 mg and Esomeprazole 20 mg) twice daily (bid) taken orally.

DRUG

Naproxen

Naproxen (500 mg) dosed twice daily (bid) orally

Trial Locations (1)

POZEN, Chapel Hill